Human keratinocytes produce the complement inhibitor factor I: Synthesis is regulated by interferon-γ

Molecular Immunology

Volumn 44, Issue 11, 2007, Pages 2943-2949

  Timár, Krisztina K ^a   Junnikkala, Sami ^b   Dallos, Attila ^c   Jarva, Hanna ^b   Bhuiyan, Zahurul A ^a   Meri, Seppo ^b   Bos, Jan D ^a   Asghar, Syed S ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Biosynthesis; Complement; Cytokines; Soluble complement regulators

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3B; COMPLEMENT INHIBITOR FACTOR; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION;

CELLS, CULTURED; COMPLEMENT FACTOR I; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA, RECOMBINANT; KERATINOCYTES; PROTEIN BIOSYNTHESIS; RNA, MESSENGER;

EID: 33947110359     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.01.007     Document Type: Article

References (44)

1. Asghar S.S., Timár K.K., and Pasch M.C. Complement as a part of the skin immune system. In: Bos J.D. (Ed). Skin Immune System. 3rd ed. (2005), CRC Press, Boca Raton 327-348
2. Barilla-LaBarca M.L., Liszewski M.K., Lambris J.D., Hourcade D., and Atkinson J.P. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. J. Immunol. 168 (2002) 6298-6304
3. Barker J.N.W.N. Epidermis as a pro-inflammatory organ. In: Bos J.D. (Ed). Skin Immune System. 3rd ed. (2005), CRC Press, Boca Raton 439-447
4. Basset-Seguin N., Caughman S.W., and Yancey K.B. A-431 cells and human keratinocytes synthesize and secrete the third component of complement. J. Invest. Dermatol. 95 (1990) 621-625
5. Blom A.M., Kask L., and Dahlback B. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b. Mol. Immunol. 39 (2003) 547-556
6. Blom A.M., Villoutreix B.O., and Dahlback B. Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?. Mol. Immunol. 40 (2004) 1333-1346
7. Bos J.D., and Kapsenberg M.L. The skin immune system: progress in cutaneous biology. Immunol. Today 14 (1993) 75-78
8. Cunnion K.M., Hair P.S., and Buescher E.S. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I. Infect. Immun. 72 (2004) 2858-2863
9. Dovezenski N., Billetta R., and Gigli I. Expression and localization of proteins of the complement system in human skin. J. Clin. Invest. 90 (1992) 2000-2012
10. Fujita T., Gigli I., and Nussenzweig V. Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator. J. Exp. Med. 148 (1978) 1044-1051
11. Fukui A., Yuasa-Nakagawa T., Murakami Y., Funami K., Kishi N., Matsuda T., Fujita T., Seya T., and Nagasawa S. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis. J. Biochem. (Tokyo) 132 (2002) 719-728
12. Giannakis E., Male D.A., Ormsby R.J., Mold C., Jokiranta T.S., Ranganathan S., and Gordon D.L. Multiple ligand binding sites on domain seven of human complement factor H. Int. Immunopharmacol. 1 (2001) 433-443
13. Gigli I., Fujita T., and Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 6596-6600
14. Goldberger G., Arnaout M.A., Aden D., Kay R., Rits M., and Colten H.R. Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (factor I) in three hepatoma cell lines. J. Biol. Chem. 259 (1984) 6492-6497
15. Greenbaum D., Colangelo C., Williams K., and Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 4 (2003) 117
16. Guc D., Gulati P., Lemercier C., Lappin D., Birnie G.D., and Whaley K. Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium. Rheumatol. Int. 13 (1993) 139-146
17. Hart S.P., Smith J.R., and Dransfield I. Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement. Clin. Exp. Immunol. 135 (2004) 181-185
18. Hellwage J., Meri T., Heikkilä T., Panelius J., Alitalo A., Lahdenne P., Seppälä I.J., and Meri S. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J. Biol. Chem. 276 (2001) 8427-8435
19. Jarva H., Janulczyk R., Hellwage J., Zipfel P.F., Björck L., and Meri S. Streptococcus pneumoniae evades complement attack and opsonophgocytosis by expressing the pspC-locus encoded Hic-protein that binds to short consensus repeats 8-11 of factor H. J. Immunol. 168 (2002) 1880-1894
20. Julen N., Dauchel H., Lemercier C., Sim R.B., Fontaine M., and Ripoche J. In vitro biosynthesis of complement factor I by human endothelial cells. Eur. J. Immunol. 22 (1992) 213-217
21. Krych-Goldberg M., and Atkinson J.P. Structure-function relationships of complement receptor type 1. Immunol. Rev. 180 (2001) 112-122
22. Legoedec J., Gasque P., Jeanne J.F., and Fontaine M. Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I. Eur. J. Immunol. 25 (1995) 3460-3466
23. Liszewski M.K., Farries T.C., Lublin D.M., Rooney I.A., and Atkinson J.P. Control of the complement system. Adv. Immunol. 61 (1996) 201-283
24. Meri S., and Pangburn M.K. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 3982-3986
25. Meri T., Hartmann A., Lenk D., Eck R., Wurzner R., Hellwage J., Meri S., and Zipfel P.F. The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect. Immun. 70 (2002) 5185-5192
26. Mevorach D., Mascarenhas J.O., Gershov D., and Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188 (1998) 2313-2320
27. Minta J.O., Fung M., and Paramaswara B. Transcriptional and post-transcriptional regulation of complement factor I (CFI) gene expression in Hep G2 cells by interleukin-6. Biochim. Biophys. Acta 1442 (1998) 286-295
28. Morris K.M., Aden D.P., Knowles B.B., and Colten H.R. Complement biosynthesis by the human hepatoma-derived cell line HepG2. J. Clin. Invest. 70 (1982) 906-913
29. Pandiripally V., Wei L., Skerka C., Zipfel P.F., and Cue D. Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci. Infect. Immun. 71 (2003) 7119-7128
30. Pangburn M.K. Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. Immunopharmacology 49 (2000) 149-157
31. Pangburn M.K., Schreiber R.D., and Muller-Eberhard H.J. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J. Exp. Med. 146 (1977) 257-270
32. Pasch M.C., Bos J.D., Daha M.R., and Asghar S.S. Transforming growth factor-beta isoforms regulate the surface expression of membrane cofactor protein (CD46) and CD59 on human keratinocytes. Eur. J. Immunol. 29 (1999) 100-108
33. Pasch M.C., van den Bosch N.H., Daha M.R., Bos J.D., and Asghar S.S. Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines. J. Invest. Dermatol. 114 (2000) 78-82
34. Sahu A., Isaa S.N., Soulika A.M., and Lambris J.D. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J. Immunol. 160 (1998) 5596-5604
35. Schlaf G., Rothermel E., Oppermann M., Schieferdecker H.L., Jungermann K., and Gotze O. Rat complement factor I: molecular cloning, sequencing and expression in tissues and isolated cells. Immunology 98 (1999) 464-474
36. Spiller O.B., Robinson M., O'Donnell E., Milligan S., Morgan B.P., Davison A.J., and Blackbourn D.J. Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J. Virol. 77 (2003) 592-599
37. Terui T., Ishii K., Ozawa M., Tabata N., Kato T., and Tagami H. C3 production of cultured human epidermal keratinocytes is enhanced by IFNgamma and TNFalpha through different pathways. J. Invest. Dermatol. 108 (1997) 62-67
38. Timár K.K., Pasch M.C., van den Bosch N.H.A., Jarva H., Junnikkala S., Meri S., Bos J.D., and Asghar S.S. Human kerinocytes produce the complement inhibitor factor H: synthesis is regulated by interferon-γ. Mol. Immunol. 43 (2006) 17-325
39. Tsuji S., Kaji K., and Nagasawa S. Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells. J. Biochem. (Tokyo) 116 (1994) 794-800
40. Venneke G.T., Vodegel R.M., Okada N., Westerhof W., Bos J.D., and Asghar S.S. Relative contributions of decay accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 in the protection of melanocytes from homologous complement. Immunobiology 198 (1998) 476-484
41. Vetvicka V., Reed W., Hoover M.L., and Ross G.D. Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3. J. Immunol. 150 (1993) 4052-4060
42. Vogel H., Halme J., and Kirschfink M. Expression of soluble and membrane-bound complement regulatory proteins by human hepatocytes. Immunopharmacology 49 (2000) 63
43. Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J. Exp. Med. 151 (1980) 501-516
44. Yancey K.B., Overholser O., Domloge-Hultsch N., Li L.J., Caughman S.W., and Bisalbutra P. Human keratinocytes and A-431 cells synthesize and secrete factor B, the major zymogen protease of the alternative complement pathway. J. Invest. Dermatol. 98 (1992) 379-383